Acumen Pharmaceuticals (ABOS) Other Accumulated Expenses (2020 - 2022)
Acumen Pharmaceuticals (ABOS) reported Other Accumulated Expenses of $37000.0 for Q3 2022, down 68.91% on a YoY basis from $119000.0 in Q3 2021, and down 63.37% sequentially from $101000.0 in Q2 2022.
Acumen Pharmaceuticals (ABOS) Other Accumulated Expenses (2020 - 2022) Analysis & Trends
Acumen Pharmaceuticals (ABOS) has 3 years of Other Accumulated Expenses data on file, last reported at $37000.0 in Q3 2022.
- For the quarter ending Q3 2022, Other Accumulated Expenses fell 68.91% year-over-year to $37000.0; the trailing twelve-month figure through Sep 2022 stood at $37000.0 (down 68.91% YoY), and the FY2021 full-year result was $204000.0, up 126.67% from the prior year.
- Other Accumulated Expenses retreated to $37000.0 in Q3 2022, from $101000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $204000.0 in Q4 2021 to a low of $37000.0 in Q3 2022.
- A 3-year average of $100285.7 and a median of $99000.0 in 2022 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses surged 126.67% in 2021 and slumped 68.91% in 2022, its largest moves.
- Tracing ABOS's Other Accumulated Expenses over 3 years: stood at $90000.0 in 2020, then surged by 126.67% to $204000.0 in 2021, then sank by 81.86% to $37000.0 in 2022.
- Business Quant data shows ABOS's Other Accumulated Expenses at $37000.0 in Q3 2022, $101000.0 in Q2 2022, and $99000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Acumen Pharmaceuticals | 140.66 Mn | 140.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 37,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 204,000.00 |
| Sep 30, 2021 | 119,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Dec 31, 2020 | 90,000.00 |